...CTI Medicalr~ I MaiMifMlurcr'i Figure 3. The prices for new products also show a moderating trend. Prices for new products approved and launched during...leading product in the same therapeutic category, according to the BCG study. In testifying on November 16 before the Senate Special Committee on Aging,...

...items. And, according to an April 1993 study by The Boston Consulting Group, prices for new products launched during 1991-1992 were on average 14 percent lower than the leading product in each therapeutic category. while managed-competition would rely on market forces to Increase competition...

...1989-1993 PERCENT CHANGES Figure 1. Prices for new products also show a moderating trend. In its study, BOG found that prices for new products approved and launched...leading product in the same therapeutic category. BCG stated, -In therapeutic areas in which multiple new products were introduced introductory prices...

...increasingly realizing lower prices at the retail level. According to the Boston Consulting Group, prices for new products approved and launched during...leading product in the same therapeutic category. Our own product Lotensin®, an ACE inhibitor, was launched at a 10-44 percent discount from leading...

...1989-1993 PERCENT CHANGES Figure 1. Prices for new products also show a moderating trend. In Its study, BCG found that prices for new products approved and launched...average 14 percent lower than the leading product in the sane therapeutic category. BCG stated, -In therapeutic areas in which multiple new products were introduced...

...Percent Increase » 1—9.5%3.1% Figure 3. Th* prices for new products also show a moderating trend. Prices for new products approved and launched during...average 14 percent lower than the leading product in the sam* therapeutic category, according to the BCG study. In testifying on November 16 before the Senate...

...forces and voluntary company actions, drug price increases have slowed dramatically during the 1990s. Prices for new products approved and launched during 1991-1992 were on average 14% lower than the leading product in the same therapeutic category. And drug price increases now are running...

...Consulting Group, which found that prices for new products approved and launched during 1991-92 were on the average 14 percent lower than the leading product in the same therapeutic In other words, private sector competition already is providing the means to lower prices for "breakthrough...

...a moderating trend. Prices for new products approved and launched during 1991-1992 were on ayerage 14 percent lower than the leading product in the same therapeutic category, according to the BCO study. In testifying on November 16 before the Senate Special Committee on Aging,...

...year's increase was the smallest in 20 years. The prices for new products also show a moderating trend. Prices for new products approved and launched during...leading product in the same therapeutic category, according to the BCG study. Producer Price Index for Pharmaceuticals Percent Increase 9.5% 8.1% 7.8%...